Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Read now
Articles from other publishers (29)
Nabil F. Saba, Saagar Pamulapati, Bhamini Patel, Mayur Mody, Primož Strojan, Robert Takes, Antti A. Mäkitie, Oded Cohen, Pia Pace-Asciak, Jan B. Vermorken, Carol Bradford, Arlene Forastiere, Yong Teng, Andreas Wieland & Alfio Ferlito. (2023) Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer. Cancers 15:7, pages 1959.
Crossref
Crossref
A. I. Stukan, R. A. Murashko, N. A. Tsygan, A. Yu. Goryainova, O. N. Nefedov & V. A. Porkhanov. (2022) Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender. Head and Neck Tumors (HNT) 12:3, pages 114-126.
Crossref
Crossref
James A. DeVoti, Mohd Israr, Fung Lam, Christopher Papayannakos, Douglas K. Frank, Dev P. Kamdar, Lucio M. Pereira, Allan Abramson, Bettie M. Steinberg & Vincent R. Bonagura. (2022) Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α. Frontiers in Immunology 13.
Crossref
Crossref
Danilo Galizia, Silvia Minei, Elena Maldi, Giovanna Chilà, Alessio Polidori & Marco Carlo Merlano. (2022) How Risk Factors Affect Head and Neck Squamous Cell Carcinoma (HNSCC) Tumor Immune Microenvironment (TIME): Their Influence on Immune Escape Mechanisms and Immunotherapy Strategy. Biomedicines 10:10, pages 2498.
Crossref
Crossref
Steven F. Gameiro, Andris M. Evans & Joe S. Mymryk. (2021)
The tumor immune microenvironments of
HPV
+
and
HPV
−
head and neck cancers
. WIREs Mechanisms of Disease 14:2.
Crossref
Crossref
Madeleine P. Strohl, Patrick K. Ha, Kaveh Zakeri & Nancy Lee. 2022. Multidisciplinary Management of Head and Neck Cancer. Multidisciplinary Management of Head and Neck Cancer
1
12
.
Huanhuan Wang, Qin Zhao, Yuyu Zhang, Qihe Zhang, Zhuangzhuang Zheng, Shiyu Liu, Zijing Liu, Lingbin Meng, Ying Xin & Xin Jiang. (2021) Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus. Frontiers in Immunology 12.
Crossref
Crossref
Adam Brewczyński, Beata Jabłońska, Agnieszka Maria Mazurek, Jolanta Mrochem-Kwarciak, Sławomir Mrowiec, Mirosław Śnietura, Marek Kentnowski, Zofia Kołosza, Krzysztof Składowski & Tomasz Rutkowski. (2021) Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer. Cancers 13:13, pages 3256.
Crossref
Crossref
Fadi Abboodi, Nella C. Delva, Jennifer Emmel, Ariana Renrick, Phillip Buckhaults, Carolyn E. Banister, Kim E. Creek & Lucia Pirisi. (2021) Human papillomavirus-mediated carcinogenesis and tumor progression. Genome Instability & Disease 2:2, pages 71-91.
Crossref
Crossref
Ke Xu, You Fu, Yong Han, Ronghui Xia, Shengming Xu, Shengzhong Duan, Zhiyuan Zhang & Jiang Li. (2020) Fewer tumour-specific PD-1+CD8+ TILs in high-risk “Infiltrating” HPV− HNSCC. British Journal of Cancer 123:6, pages 932-941.
Crossref
Crossref
Hasan Baysal, Ines De Pauw, Hannah Zaryouh, Jorrit De Waele, Marc Peeters, Patrick Pauwels, Jan Baptist Vermorken, Evelien Smits, Filip Lardon, Julie Jacobs & An Wouters. (2020) Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status. British Journal of Cancer 123:5, pages 752-761.
Crossref
Crossref
Hao-fan Wang, Sha-sha Wang, Ya-Jie Tang, Yu Chen, Min Zheng, Ya-ling Tang & Xin-hua Liang. (2019) The Double-Edged Sword—How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Ede Birtalan, Kornel Danos, Bianka Gurbi, Diana Brauswetter, Judit Halasz, Violetta Kalocsane Piurko, Balazs Acs, Biborka Antal, Reka Mihalyi, Anna Pato, Zoltan Fent, Gabor Polony, Jozsef Timar & Laszlo Tamas. (2018) Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer. Applied Immunohistochemistry & Molecular Morphology 26:7, pages e79-e85.
Crossref
Crossref
Shao Hui Huang, Brian O'Sullivan & John Waldron. (2018) The Current State of Biological and Clinical Implications of Human Papillomavirus-Related Oropharyngeal Cancer. Seminars in Radiation Oncology 28:1, pages 17-26.
Crossref
Crossref
Maria Agarwal & Cornelia Trimble. 2018. Oncoimmunology. Oncoimmunology
263
274
.
Oliver Wood, James Clarke, Jeongmin Woo, Adal H. Mirza, Christopher H. Woelk, Gareth J. Thomas, Pandurangan Vijayanand, Emma King & Christian H. Ottensmeier. (2017) Head and Neck Squamous Cell Carcinomas Are Characterized by a Stable Immune Signature Within the Primary Tumor Over Time and Space. Clinical Cancer Research 23:24, pages 7641-7649.
Crossref
Crossref
M. Taberna, M. Mena, M.A. Pavón, L. Alemany, M.L. Gillison & R. Mesía. (2017) Human papillomavirus-related oropharyngeal cancer. Annals of Oncology 28:10, pages 2386-2398.
Crossref
Crossref
Zipei Feng, Daniel Bethmann, Matthias Kappler, Carmen Ballesteros-Merino, Alexander Eckert, R. Bryan Bell, Allen Cheng, Tuan Bui, Rom Leidner, Walter J. Urba, Kent Johnson, Clifford Hoyt, Carlo B. Bifulco, Juergen Bukur, Claudia Wickenhauser, Barbara Seliger & Bernard A. Fox. (2017) Multiparametric immune profiling in HPV– oral squamous cell cancer. JCI Insight 2:14.
Crossref
Crossref
Jonathan Moreira, Alexander Tobias, Michael P. O’Brien & Mark Agulnik. (2017) Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies. Drugs 77:8, pages 843-857.
Crossref
Crossref
Yu Lei, Yuying Xie, Yee Sun Tan, Mark E. Prince, Jeffrey S. Moyer, Jacques Nör & Gregory T. Wolf. (2016) Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer. Oral Oncology 61, pages 159-165.
Crossref
Crossref
Yanxiao Zhang, Lada A. Koneva, Shama Virani, Anna E. Arthur, Alisha Virani, Pelle B. Hall, Charles D. Warden, Thomas E. Carey, Douglas B. Chepeha, Mark E. Prince, Jonathan B. McHugh, Gregory T. Wolf, Laura S. Rozek & Maureen A. Sartor. (2016) Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures. Clinical Cancer Research 22:18, pages 4735-4745.
Crossref
Crossref
Zipei Feng, Carlo B. Bifulco, Rom Leidner, R. Bryan Bell & Bernard A. Fox. 2016. Targeting Oral Cancer. Targeting Oral Cancer
211
224
.
Gayani Pitiyage, Mary Lei, Teresa Guererro Urbano, Edward Odell & Selvam Thavaraj. (2015) Biphenotypic human papillomavirus-associated head and neck squamous cell carcinoma: a report of two cases. Diagnostic Pathology 10:1.
Crossref
Crossref
Suzanne E. Brooks, Stephanie A. Bonney, Cindy Lee, Amy Publicover, Ghazala Khan, Evelien L. Smits, Dagmar Sigurdardottir, Matthew Arno, Demin Li, Ken I. Mills, Karen Pulford, Alison H. Banham, Viggo van Tendeloo, Ghulam J. Mufti, Hans-Georg Rammensee, Tim J. Elliott, Kim H. Orchard & Barbara-ann Guinn. (2015) Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis. PLOS ONE 10:10, pages e0140483.
Crossref
Crossref
Robert L. Ferris. (2015) Immunology and Immunotherapy of Head and Neck Cancer. Journal of Clinical Oncology 33:29, pages 3293-3304.
Crossref
Crossref
Xu Qian, Chenming Ma, Xiaobo Nie, Jianxin Lu, Minoo Lenarz, Andreas M. Kaufmann & Andreas E. Albers. (2015) Biology and immunology of cancer stem(-like) cells in head and neck cancer. Critical Reviews in Oncology/Hematology 95:3, pages 337-345.
Crossref
Crossref
Benjamin A. Kansy, Nicole C. Schmitt & Robert L. Ferris. (2015) Immune Escape and Immunotherapy of HPV-Related Oropharyngeal Cancer: Has the Future Arrived?. Current Otorhinolaryngology Reports 3:2, pages 63-72.
Crossref
Crossref
Shao Hui Huang, John N. Waldron, Michael Milosevic, Xiaowei Shen, Jolie Ringash, Jie Su, Li Tong, Bayardo Perez-Ordonez, Ilan Weinreb, Andrew J. Bayley, John Kim, Andrew Hope, B.C. John Cho, Meredith Giuliani, Albiruni Razak, David Goldstein, Willa Shi, Fei-Fei Liu, Wei Xu & Brian O'Sullivan. (2015) Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer 121:4, pages 545-555.
Crossref
Crossref
Nicole C. Schmitt, Robert L. Ferris & Seungwon Kim. 2015. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer
291
306
.